Visalytics
Visalytics
approved EB-2 (NIW)

Clinical Research Coordinator-Intermediate

Biomedical Sciences · Pakistan · 2025-05-12

Processing Time
47 days
Decision Date
2025-05-12
Location
Michigan
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance disease prevention and treatment strategies, specifically focusing on inflammatory bowel disease, heart disease, autoimmune disorders, and novel infections. The work involves optimizing and synthesizing predictive, therapeutic, and diagnostic modalities to improve clinical outcomes for pressing health issues.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical healthcare burdens including heart disease and autoimmune disorders, aligning with national interests in AI and biotechnology.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 1,050 citations and 42 publications demonstrates a high level of expertise and influence in the field.

3 Balance of Factors to Waive Job Offer Met

Given the petitioner's significant contributions and the urgent need for medical research advancement, it was found beneficial to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 42 peer-reviewed journal articles and 53 conference abstracts which garnered 1,050 citations. Additional evidence included 83 peer reviews for top journals, editorial board memberships, and research support from the NIH and the National Institute of Diabetes and Digestive and Kidney Diseases. All three Dhanasar prongs were satisfied without a Request for Evidence.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Judging Experience
Grants
Government Alignment

Similar Cases

Physician

Healthcare · China

WeGreened EB-2 (NIW) approved
8 days 2023-08-08
The petitioner proposes to advance the development of new treatments for prevalent medical disorders, specifically cancer, heart failure, and heart attacks, by conducting research on disease mechanisms. Her work focuses on improving the diagnosis, treatment, and prevention of these leading causes of global mortality.
View Case

Doctor

Healthcare · Turkey

WeGreened EB-2 (NIW) approved
New York 15 days 2025-04-17
The petitioner proposes to enhance the understanding of chronic diseases, including cancer, diabetes, and cardiovascular illnesses, by exploring genetic predispositions and novel chemopreventive agents. His work focuses on improving therapeutic efficacy and reducing public health burdens through innovative, patient-focused strategies and translational immunotherapy research.
View Case

Postdoctoral Researcher

Biotechnology · Pakistan

WeGreened EB-2 (NIW) approved
Massachusetts 68 days 2022-04-30
The petitioner proposes to continue research on the development of state-of-the-art pipelines, algorithms, and systems to predict disease-specific biomarkers and drug effects. His work involves studying the viral microbiome, performing single-cell and epigenetic analyses of gastrointestinal tissue, and investigating noncoding RNAs related to COVID-19, inflammatory bowel disease, and liver fibrosis.
View Case

Doctor

Healthcare · Syria

WeGreened EB-2 (NIW) approved
Ohio 603 days 2025-10-11
The petitioner proposes to continue advancing patient-centric healthcare and medical research in the United States. Their work focuses on clinical practices and public health strategies, specifically addressing COVID-19 vaccination awareness, artificial intelligence in clinical settings, cardiac electrophysiology, and therapeutic optimization for cancer treatments. The endeavor aims to improve patient outcomes and strengthen U.S. public health systems through evidence-based care.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Pakistan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-12.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 47 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Pakistan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist